Shanghai Fosun Pharmaceutical (02196) acquired 1.195 billion shares of its controlling shareholder Fosun High-Tech as collateral and released 1.24 billion shares of the company's stock.

Shanghai Fosun Pharmaceutical (02196) announced that on February 13, 2025, the company received a notification from its controlling shareholder Shanghai Fosun High-Tech (Group) Co., Ltd. ("Fosun High-Tech") that it has pledged and released part of its A shares held by the company. On February 12, 2025, Fosun High-Tech jointly pledged a total of 119.5 million shares of the company to Industrial and Commercial Bank of China Shanghai Changning Branch to repay debts. On the same day, 124 million shares of the company were released from pledge. After this pledge and release, the remaining number of shares pledged by Fosun High-Tech is 707.3 million shares (all A shares), accounting for approximately 26.48% of the total number of shares as of the date.